SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17062758
Source:
http://linkedlifedata.com/resource/pubmed/id/17062758
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0011860
,
umls-concept:C0021655
,
umls-concept:C0028754
,
umls-concept:C0030705
,
umls-concept:C0071097
,
umls-concept:C0087111
,
umls-concept:C0205191
,
umls-concept:C1880497
,
umls-concept:C1996904
pubmed:issue
1
pubmed:dateCreated
2007-1-8
pubmed:abstractText
Thiazolidinediones increase peripheral insulin sensitivity and decrease plasma free fatty acids (FFA). However, their exact mechanism of action has not been fully elucidated.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0375362
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adiponectin
,
http://linkedlifedata.com/resource/pubmed/chemical/Ceramides
,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Nonesterified
,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose
,
http://linkedlifedata.com/resource/pubmed/chemical/Glucosylceramides
,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones
,
http://linkedlifedata.com/resource/pubmed/chemical/pioglitazone
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0021-972X
pubmed:author
pubmed-author:AckermansMariette TMT
,
pubmed-author:AertsJohannes MJM
,
pubmed-author:AllickGideonG
,
pubmed-author:GroenerJohanna EJE
,
pubmed-author:HeijligenbergRikR
,
pubmed-author:MeijerAlfred JAJ
,
pubmed-author:SauerweinHans PHP
,
pubmed-author:SerlieMireille JMJ
,
pubmed-author:VoermansBarbara CBC
pubmed:issnType
Print
pubmed:volume
92
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
166-71
pubmed:meshHeading
pubmed-meshheading:17062758-Adiponectin
,
pubmed-meshheading:17062758-Ceramides
,
pubmed-meshheading:17062758-Diabetes Mellitus, Type 2
,
pubmed-meshheading:17062758-Fatty Acids, Nonesterified
,
pubmed-meshheading:17062758-Female
,
pubmed-meshheading:17062758-Glucose
,
pubmed-meshheading:17062758-Glucosylceramides
,
pubmed-meshheading:17062758-Humans
,
pubmed-meshheading:17062758-Hypoglycemic Agents
,
pubmed-meshheading:17062758-Insulin Resistance
,
pubmed-meshheading:17062758-Male
,
pubmed-meshheading:17062758-Obesity
,
pubmed-meshheading:17062758-Regression Analysis
,
pubmed-meshheading:17062758-Thiazolidinediones
pubmed:year
2007
pubmed:articleTitle
Chronic treatment with pioglitazone does not protect obese patients with diabetes mellitus type II from free fatty acid-induced insulin resistance.
pubmed:affiliation
Department of Endocrinology and Metabolism, Academic Medical Center, F5-169, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. m.j.serlie@amc.uva.nl
pubmed:publicationType
Journal Article